, the Union Health Ministry said as India’s case count mounted to 15,83,792 and the death toll rose to 34,968.ixteen states and UTs, including Delhi, Gujarat Tamil Nadu and Madhya Pradesh, have a COVID-19 recovery rate higher than the national average of 64.44%
COVID-19 Recovery Rate
The gap between recovered patients and active COVID-19 cases currently stands at 4,92,340. With this figure, the recovered cases are 1.9 times the active cases. The State/ UT governments have taken many measures at the ground level to increase affordable hospital infrastructure for seamless clinical management. The success can also be seen with 16 States/ UTs recording higher recovery rates than the national average rate.
Some of the sixteen states and UTs are Delhi (88.99%), (80.38%), Haryana (78.56%), Assam (76.68%), Telangana (74.27%), Tamil Nadu (73.85%), Gujarat (73.06%), Rajasthan (70.76%), Madhya Pradesh (69.47%), Goa (68.94%).
Gilead Sciences Inc. has said it expects to make more than 2 million doses of Covid-19 treatment remdesivir by the end of the year. According to Anthony Fauci, director, National Institute of Allergy and Infectious Diseases (NIAID) of the US, India’s position as the world’s largest vaccine manufacturer by volume will play a crucial role when an effective vaccine is developed globally and the US government is monitoring the vaccine development efforts of Indian companies through its 30-year-old partnership with India’s department of biotechnology.
Post COVID-19 Recovery
However, symptoms and complications have continued to persist in the majority of people, even after 2 months of their recovery. While many reported body aches and breathlessness, there are also cases of significant organ dysfunction, mainly the lungs and brain. A latest study conducted in Italy shows an overwhelming 87% of patients recovered from COVID-19 reported persistence of at least one symptom, particularly fatigue and dyspnea.